🐜
|
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
15 auth.
P. Tiberghien,
C. Ferrand,
B. Lioure,
N. Milpied,
R. Angonin,
E. Deconinck,
J. Certoux,
É. Robinet,
P. Saas,
B. Petracca,
...
C. Juttner,
Craig W. Reynolds,
D. Longo,
P. Hervé,
J. Cahn
|
8 |
2001 |
8 🐜
|
🐜
|
Evidence of premature immune aging in patients thymectomized during early childhood.
10 auth.
D. Sauce,
M. Larsen,
Soléne Fastenackels,
A. Duperrier,
Michael Keller,
B. Grubeck‐Loebenstein,
...
C. Ferrand,
P. Debré,
D. Sidi,
V. Appay
|
7 |
2009 |
7 🐜
|
🐜
|
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
20 auth.
M. Pasquet,
C. Bellanné-Chantelot,
S. Tavitian,
N. Prade,
B. Beaupain,
O. Larochelle,
A. Petit,
P. Rohrlich,
C. Ferrand,
E. Van Den Neste,
...
H. Poirel,
T. Lamy,
M. Ouachée-Chardin,
V. Mansat-De Mas,
J. Corre,
C. Récher,
G. Plat,
F. Bachelerie,
J. Donadieu,
É. Delabesse
|
7 |
2013 |
7 🐜
|
🐜
|
Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.
9 auth.
D. Ducloux,
M. Deschamps,
Maria Yannaraki,
C. Ferrand,
J. Bamoulid,
P. Saas,
...
A. Kazory,
J. Chalopin,
P. Tiberghien
|
7 |
2005 |
7 🐜
|
🐜
|
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
20 auth.
F. Garnache-Ottou,
J. Feuillard,
C. Ferrand,
S. Biichlé,
F. Trimoreau,
E. Seillès,
V. Salaun,
R. Garand,
P. Lepelley,
M. Maynadie,
...
E. Kuhlein,
E. Deconinck,
S. Daliphard,
L. Chaperot,
Lucille Beseggio,
Vincent Foisseaud,
E. Macintyre,
M. Béné,
P. Saas,
M. Jacob
|
7 |
2009 |
7 🐜
|
🐜
|
Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms.
13 auth.
D. Sauce,
M. Bodinier,
M. Garin,
B. Petracca,
Nicolas Tonnelier,
A. Duperrier,
J. Melo,
J. Apperley,
C. Ferrand,
P. Hervé,
...
F. Lang,
P. Tiberghien,
É. Robinet
|
7 |
2002 |
7 🐜
|
🐜
|
IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells
12 auth.
V. Dardalhon,
S. Jaleco,
S. Kinet,
B. Herpers,
M. Steinberg,
C. Ferrand,
...
D. Froger,
C. Leveau,
P. Tiberghien,
P. Charneau,
N. Noraz,
N. Taylor
|
6 |
2001 |
6 🐜
|
🐜
|
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.
20 auth.
F. Garnache-Ottou,
L. Chaperot,
S. Biichlé,
C. Ferrand,
J. Rémy-Martin,
E. Deconinck,
P. D. de Tailly,
B. Bulabois,
J. Poulet,
E. Kuhlein,
...
M. Jacob,
V. Salaun,
M. Arock,
B. Drénou,
F. Schillinger,
E. Seillès,
P. Tiberghien,
J. Bensa,
J. Plumas,
P. Saas
|
6 |
2004 |
6 🐜
|
🐜
|
Neuropilin-2 Expression Promotes TGF-β1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells
13 auth.
C. Grandclément,
Jean-René Pallandre,
S. Valmary Degano,
E. Viel,
A. Bouard,
Jérémy Balland,
J. Rémy-Martin,
B. Simon,
Alain Rouleau,
W. Boireau,
...
M. Klagsbrun,
C. Ferrand,
C. Borg
|
6 |
2011 |
6 🐜
|
🐜
|
Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.
11 auth.
R. Bedel,
A. Thiery-Vuillemin,
C. Grandclément,
Jérémy Balland,
J. Rémy-Martin,
B. Kantelip,
...
Jean-René Pallandre,
X. Pivot,
C. Ferrand,
P. Tiberghien,
C. Borg
|
6 |
2011 |
6 🐜
|